NVX PE Ratio & Valuation,Is NVX Overvalued

NVX Relative Valuation

NVX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NVX is overvalued; if below, it's undervalued.

Historical Valuation

NOVONIX Ltd (NVX) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.95 is considered Undervalued compared with the five-year average of -33.83. The fair price of NOVONIX Ltd (NVX) is between 1.31 to 7.24 according to relative valuation methord. Compared to the current price of 1.00 USD , NOVONIX Ltd is Undervalued By 23.51%.

Relative Value

Fair Zone

1.31-7.24

Current Price：1.00

23.51%

Undervalued

0.00

-8.83

EV/EBITDA

NOVONIX Ltd. (NVX) has a current EV/EBITDA of -8.83. The 5-year average EV/EBITDA is -30.21. The thresholds are as follows: Strongly Undervalued below -146.35, Undervalued between -146.35 and -88.28, Fairly Valued between 27.87 and -88.28, Overvalued between 27.87 and 85.94, and Strongly Overvalued above 85.94. The current Forward EV/EBITDA of -8.83 falls within the Historic Trend Line -Fairly Valued range.

-6.72

EV/EBIT

NOVONIX Ltd. (NVX) has a current EV/EBIT of -6.72. The 5-year average EV/EBIT is -9.88. The thresholds are as follows: Strongly Undervalued below -101.82, Undervalued between -101.82 and -55.85, Fairly Valued between 36.09 and -55.85, Overvalued between 36.09 and 82.06, and Strongly Overvalued above 82.06. The current Forward EV/EBIT of -6.72 falls within the Historic Trend Line -Fairly Valued range.

2.95

NOVONIX Ltd. (NVX) has a current PS of 2.95. The 5-year average PS is 66.61. The thresholds are as follows: Strongly Undervalued below -98.65, Undervalued between -98.65 and -16.02, Fairly Valued between 149.24 and -16.02, Overvalued between 149.24 and 231.86, and Strongly Overvalued above 231.86. The current Forward PS of 2.95 falls within the Historic Trend Line -Fairly Valued range.

1.79

P/OCF

NOVONIX Ltd. (NVX) has a current P/OCF of 1.79. The 5-year average P/OCF is -54.58. The thresholds are as follows: Strongly Undervalued below -222.26, Undervalued between -222.26 and -138.42, Fairly Valued between 29.26 and -138.42, Overvalued between 29.26 and 113.10, and Strongly Overvalued above 113.10. The current Forward P/OCF of 1.79 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/FCF

NOVONIX Ltd. (NVX) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

NOVONIX Ltd (NVX) has a current Price-to-Book (P/B) ratio of 4.53. Compared to its 3-year average P/B ratio of 2.96 , the current P/B ratio is approximately 53.36% higher. Relative to its 5-year average P/B ratio of 4.78, the current P/B ratio is about -5.10% higher. NOVONIX Ltd (NVX) has a Forward Free Cash Flow (FCF) yield of approximately -40.48%. Compared to its 3-year average FCF yield of -29.28%, the current FCF yield is approximately 38.22% lower. Relative to its 5-year average FCF yield of -20.08% , the current FCF yield is about 101.62% lower.

4.49

P/B

Median3y

2.96

Median5y

4.78

-40.55

FCF Yield

Median3y

-29.28

Median5y

-20.08

Competitors Valuation Multiple

The average P/S ratio for NVX's competitors is 1.48, providing a benchmark for relative valuation. NOVONIX Ltd Corp (NVX) exhibits a P/S ratio of 2.95, which is 100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of NVX increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of NVX in the past 1 year is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is NOVONIX Ltd (NVX) currently overvalued or undervalued?

What is NOVONIX Ltd (NVX) fair value?

NVX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of NOVONIX Ltd (NVX) is between 1.31 to 7.24 according to relative valuation methord.

How does NVX's valuation metrics compare to the industry average?

The average P/S ratio for NVX's competitors is 1.48, providing a benchmark for relative valuation. NOVONIX Ltd Corp (NVX) exhibits a P/S ratio of 2.95, which is 100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for NOVONIX Ltd (NVX) as of Dec 16 2025?

As of Dec 16 2025, NOVONIX Ltd (NVX) has a P/B ratio of 4.53. This indicates that the market values NVX at 4.53 times its book value.

What is the current FCF Yield for NOVONIX Ltd (NVX) as of Dec 16 2025?

As of Dec 16 2025, NOVONIX Ltd (NVX) has a FCF Yield of -40.48%. This means that for every dollar of NOVONIX Ltd’s market capitalization, the company generates -40.48 cents in free cash flow.

What is the current Forward P/E ratio for NOVONIX Ltd (NVX) as of Dec 16 2025?

As of Dec 16 2025, NOVONIX Ltd (NVX) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of NOVONIX Ltd’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for NOVONIX Ltd (NVX) as of Dec 16 2025?

As of Dec 16 2025, NOVONIX Ltd (NVX) has a Forward P/S ratio of 2.95. This means the market is valuing NVX at $2.95 for every dollar of expected revenue over the next 12 months.

NVX Valuation